ATCT-22 NRG ONCOLOGY/RTOG 1122: PHASE II DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF BEVACIZUMAB WITH OR WITHOUT AMG 386 IN PATIENTS WITH RECURRENT GLIOBLASTOMA OR GLIOSARCOMA

Saved in:
Bibliographic Details
Published in:Neuro Oncol
Main Authors: Lee, Eudocia Q., Zhang, Peixin, Wen, Patrick Y., Gerstner, Elizabeth R., Reardon, David A., Aldape, Ken, de Groot, John F., Choe, Kevin S., Raizer, Jeffrey J., Kim, Lyndon J., Chmura, Steven J., Robins, H. Ian, Connelly, Jennifer, Battiste, James, Villano, John, Wagle, Naveed, Merrell, Ryan T., Wendland, Merideth, Mehta, Minesh P.
Format: Artigo
Language:Inglês
Published: Oxford University Press 2015
Subjects:
Abstracts from the 20th Annual Scientific Meeting of the Society for Neuro-Oncology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4638573/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov206.22
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items